IIFL Securities Stock Market Watch Today: Buy Max Healthcare Ins - June 12

IIFL Securities issued a "buy" recommendation for Max Healthcare Insurance on June 12 with a target price of Rs 878, representing an upside potential of approximately 3.7% from the current market price of Rs 846.95. This recommendation aligns with bullish market sentiment and positive expectations for the company's performance in the coming quarters.

About Max Healthcare Ins:

Max Healthcare Institute Limited (Max Healthcare Ins) is a leading provider of healthcare services in India. The company operates a network of 16 hospitals in North India, with a total capacity of over 2,400 beds. Max Healthcare Ins offers a wide range of medical services, including cardiac care, oncology, neurosciences, and orthopedics. The company also has a strong presence in the preventive healthcare segment, with a network of over 100 diagnostic centers and clinics. Max Healthcare Ins is a listed company on the National Stock Exchange of India (NSE) and is a part of the Max Group, one of India's leading business conglomerates.

52 Week Price Trend:

Max Healthcare Institute's stock is currently trading at Rs 846.95, near its 52-week low of Rs 411.9. The stock had reached a 52-week high of Rs 910 earlier this year. The company's financial performance in recent quarters has been impacted by the COVID-19 pandemic, leading to a decline in its stock price. However, the stock has recently shown signs of recovery, with the company reporting improved earnings in the second quarter of the current fiscal year. Analysts believe that the stock has the potential for further upside in the long term due to the company's strong brand recognition and growing presence in the healthcare sector.

Stratzy's MOST Analysis:

Based on the MOST framework, MAXHEALTH has received an AA rating. This framework analyzes a company's management, outlook, safety, and trend to assess its fundamental risks. The AA rating suggests MAXHEALTH has a solid management team, positive industry outlook, strong financial stability, and a favorable market trend. This indicates that MAXHEALTH carries medium fundamental risks, indicating a relatively stable and promising investment opportunity.

Company's Fundamentals:

Max Healthcare Ins (NSE:MAXHEALTH) is a publicly traded company on the National Stock Exchange (NSE) in India. As of a certain point in time, the company's stock was trading with a Price to Earnings (PE) ratio of 76.78. This metric represents the ratio of the company's current stock price to its annual earnings per share. The Price to Book (PB) ratio of 10.34 indicates the relationship between the company's market value and its book value, which is the value of its assets minus liabilities. Finally, the Dividend Yield of 0.12% reflects the annual dividend paid by the company as a percentage of its current stock price.

Fundamental and Technical information provided in this blog were last updated on 12 Jun, 2024

Disclaimer: The information and recommendations presented in this section, including any attached reports, are sourced from third-party providers through diverse channels. The views and opinions expressed within these materials belong solely to their respective creators. These views and opinions do not necessarily reflect the position of Stratzy Fintech Pvt Ltd. Stratzy explicitly disclaims any guarantees, express or implied, regarding the accuracy and reliability of the provided content. We strongly advise consulting with a licensed financial advisor before making any investment decisions based on this information. Remember, seeking independent financial advice is crucial.